About this Research Topic
The goal of this Research Topic is to offer an opportunity of better bridging the basic science research and clinical translation for current nanomedicine development. To fill the gap in scientific advances and clinical practice may increase the success rate of clinical nanomedicine development while effectively decreasing the consumption of resources, thus lower the overall cost throughout the healthcare process. The joint efforts in nanoscience, biomedical and pharmaceutical research are much needed to overcome the multiple obstacles in the critical path of nanomedicine translation. Discussions and communications are warmly welcomed among research scientists, chemical and medical engineers, regulatory representatives, physicians and patients. We welcome Original Research, Review, Mini Review and Perspective articles on themes including, but not limited to:
• Understandings of physicochemical properties of nanomaterials that improve the stability, bioavailability, delivery and therapeutic effect, and safety
• Discoveries in nano-bio interactions, nanomedicine transport in vivo, and related physiology/pathophysiology
• Emerging techniques and method optimization in the characterization, production and purification of nanomaterial-based therapeutics
• Lessons learnt in the clinical investigation of nanomedicines and nanoformulations
• Potential approaches to improving quality control and regulatory guidelines, to establishing widely acceptable international standards, and to facilitating nanomedicine translation
Keywords: Nanomedicine, Drug Delivery, Pharmaceutical Development, Therapeutics, Clinical Trials
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.